Back to UBS Group AG UBS Group AG

APREAPRE
14 quarters

Position history for UBS Group AGUBS Group AG's holdings in APREA THERAPEUTICS INC

UBS Group AG holds 3 shares of APRE (APREA THERAPEUTICS INC), worth $2 as of 2026-Q2. The position was decreased (-99.9% shares).

Current Value

$2

Current Shares

3

Total Value Change

-$2,990

Total Shares Change

-671

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
3
-99.9%
$20.0%$0.80
0
2026-Q1
Decreased
2,153
-12.5%
$1,6430.0%$0.85
0
2025-Q4
Increased
2,461
+819x
$2,1000.0%$0.89
13
2025-Q3
Decreased
3
-62.5%
$40.0%$1.51
0
2025-Q2
Increased
8
+166.7%
$130.0%$1.67
12
2025-Q1
Decreased
3
-100.0%
$60.0%$2.09
0
2024-Q4
Increased
5,935
+1977x
$19,5260.0%$3.48
20
2024-Q3
Unchanged
3
0.0%
$80.0%$2.75
0
2024-Q2
Unchanged
3
0.0%
$120.0%$4.07
0
2024-Q1
Unchanged
3
0.0%
$200.0%$6.69
0
2023-Q4
Unchanged
3
0.0%
$140.0%$4.70
0
2023-Q3
Unchanged
3
0.0%
$130.0%$4.17
0
2023-Q2
Decreased
3
-99.5%
$90.0%$2.98
0
2023-Q1
New
674
-
$2,9920.0%$4.60
20

Other major holders of APRE: VANGUARD GROUP INC, Walleye Capital LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used